European Archives - Page 90 of 1112 - European Medical Journal

Study Shows COVID-19 Pandemic Impacted Reproductive Decisions in Sweden

A study from Southern Sweden has revealed that the COVID-19 pandemic led to a decline in birth rates and significant shifts in abortion trends.

Repeated COVID-19 Infections Increase Long COVID Risk

Individuals who experience multiple COVID-19 infections are at greater risk of developing post-acute sequelae of COVID-19.

Ethnic Disparities in Colorectal Cancer Diagnosis Uncovered in NHS Study

A major NHS study has found significant ethnic disparities in colorectal cancer diagnosis, with non-white patients more likely to develop early-onset CRC but less likely to be diagnosed through urgent referrals.

Scalp Microbiome and Central Centrifugal Cicatricial Alopecia

A recent study examined the scalp microbiome in Black women diagnosed with central centrifugal cicatricial alopecia, compared with matched healthy individuals.

Myval Transcatheter Heart Valve Matches SAPIEN and Evolut in 30-Day Performance

The Myval THV series is non-inferior to SAPIEN and Evolut THV series at 30 days, offering a promising TAVI alternative.

Climate Change and Its Impact on Urological Health

Benign urological conditions are also influenced by climate change as research indicates a correlation between rising temperatures and dehydration-related conditions.

Circulating cAMP Identified as Potential Asthma Biomarker

New research suggests that elevated circulating cAMP levels could serve as a potential biomarker for asthma.

Exercise May Boost Brain Function by Enhancing Insulin Sensitivity

Exercise shown to directly affect how the brain responds to insulin in new study.

Lupus nephritis drug delivers promising results, says Roche

Obinutuzumab could reshape the treatment of lupus nephritis, a life-threatening complication of lupus that has long lacked effective options.

Promising Stroke Treatment: Butylphthalide Slows Cognitive Decline

Butylphthalide reduces cognitive decline in stroke survivors over 12 months, offering promising neuroprotection for post-stroke care.